WeSave! Charity Play Day Three Results & Day Four Schedule
WeSave! Charity Play Day Three results Day Four Schedule ⚡⚡⚡ Esports news, analytics, reviews on WePlay! The latest news on WePlay!
The third day of WeSave! Charity Play online marathon is over. The teams from Southeast Asia, CIS, and North America played the second semi-finals and now we know the participants for the grand finals of three regions. Let's take a look at the results, highlights, and the schedule for Monday.
Sunday, March 22 Results
TNC Predator 1:2 Team Adroit. Quite an unpredictable outcome. TI winner ana joined TNC to replace Gabbi in these series and they've started pretty well, but then failed to show us their true potential. Team Adroit were better, they had chemistry, luck and so proceeded.
Virtus.pro 1:2 HellRaisers. The greatest surprise of the tournament. Everyone was expecting VP to meet NAVI in the grand finals, but HR did a decent job. Man of the series — RodjER. Just watch the highlights below and you'll get it!
Evil Geniuses 2:1 Business Associates. This one was fun, as we've had two games per 19 minutes and a decider than. Fear's crew were first to earn a point, then EG came back and won the series.
WeSave! Charity Play Day Three Best Moments
Schedule for March, 23
11:00 UTC — Broadcast launches;
12:00 UTC — China: EHOME vs Vici Gaming;
16:00 UTC — Europe: Team Secret vs Team Nigma;
19:00 UTC — South America: Beastcoast vs Thunder Predator.
You can get all the latest news through our special tag!
And of course, here's our Twitch: https://www.twitch.tv/weplaydota
Before the start of Day Four, we're at the mark of $149,670.2 collected. Just a bit more to reach the first milestone!
WeSave! Charity Play online nonprofit marathon will is held from March 20 to 26. 24 teams from six regions will battle each other inside their regions. The prize pool is set to $120,000 — all of them will go to specific organizations fighting COVID-19.
Stay safe, stay strong and stay tuned by following our special tag!
#weplay2save #Coronavirus #OutsmartEpidemics